Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATOS | TMO | ISRG | EW | ALC |
| Company | Atossa Therapeutics Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Alcon Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 0.9700 | 516.69 | 521.45 | 73.30 | 84.18 |
| High | 1.0200 | 526.43 | 530.97 | 75.27 | 85.33 |
| Low | 0.9600 | 515.00 | 516.18 | 72.97 | 84.06 |
| Last | 0.9637 | 524.05 | 524.43 | 74.81 | 84.76 |
| Change | -0.0163 | +7.36 | +0.52 | +0.88 | +0.58 |
| % Change | -1.66% | +1.42% | +0.10% | +1.19% | +0.69% |
| Volume | 1,088,800 | 2,758,800 | 3,934,100 | 14,210,400 | 917,600 |
| 20-Day Average Volume | 952,580 | 2,272,155 | 1,411,530 | 5,591,930 | 839,470 |
| Previous Close | 0.9800 | 516.69 | 523.91 | 73.93 | 84.18 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1752 | 525.53 | 540.32 | 72.53 | 86.29 |
| 20-Day Raw Stochastic | 0.93% | 47.91% | 20.60% | 92.23% | 17.98% |
| 20-Day Relative Strength | 29.50% | 43.45% | 47.02% | 60.59% | 38.79% |
| Weighted Alpha | -11.62 | -6.43 | +52.32 | +8.37 | +3.75 |
| Today's Opinion | 100% Sell | 88% Sell | 64% Buy | 24% Buy | 88% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 64% Buy | 8% Buy | 72% Sell |
| Last Month's Opinion | 24% Sell | 72% Sell | 100% Buy | 40% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.96% since 12/13/24 | -0.54% since 12/13/24 | -2.81% since 12/13/24 | +2.03% since 12/13/24 | +0.70% since 12/13/24 |
| Low | 0.9600 on 12/20/24 | 508.86 on 12/19/24 | 516.18 on 12/20/24 | 72.29 on 12/19/24 | 83.80 on 12/16/24 |
| High | 1.1500 on 12/16/24 | 535.94 on 12/17/24 | 547.90 on 12/16/24 | 75.27 on 12/20/24 | 86.50 on 12/18/24 |
| 1-Month | |||||
| %Chg | -19.69% since 11/20/24 | +2.19% since 11/20/24 | -3.21% since 11/20/24 | +7.58% since 11/20/24 | -0.87% since 11/20/24 |
| Low | 0.9600 on 12/20/24 | 507.17 on 11/22/24 | 516.18 on 12/20/24 | 69.16 on 11/21/24 | 83.80 on 12/16/24 |
| High | 1.3600 on 11/25/24 | 542.40 on 12/10/24 | 556.23 on 12/06/24 | 75.27 on 12/20/24 | 89.14 on 11/29/24 |
| 3-Month | |||||
| %Chg | -33.99% since 09/20/24 | -14.61% since 09/20/24 | +7.86% since 09/20/24 | +11.94% since 09/20/24 | -13.05% since 09/20/24 |
| Low | 0.9600 on 12/20/24 | 493.30 on 11/19/24 | 470.06 on 10/07/24 | 64.00 on 10/07/24 | 83.80 on 12/16/24 |
| High | 1.6600 on 11/11/24 | 623.77 on 09/27/24 | 556.23 on 12/06/24 | 75.27 on 12/20/24 | 100.71 on 10/01/24 |
| 6-Month | |||||
| %Chg | -13.18% since 06/20/24 | -5.95% since 06/20/24 | +21.24% since 06/20/24 | -15.79% since 06/20/24 | -5.23% since 06/20/24 |
| Low | 0.9600 on 12/20/24 | 493.30 on 11/19/24 | 413.82 on 07/18/24 | 58.93 on 07/25/24 | 83.80 on 12/16/24 |
| High | 1.6600 on 11/11/24 | 627.88 on 09/10/24 | 556.23 on 12/06/24 | 95.25 on 07/11/24 | 101.10 on 09/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 121,234 | 200,449,120 | 186,790,944 | 44,122,936 | 41,807,364 |
| Shares Outstanding, K | 125,801 | 382,500 | 356,179 | 589,800 | 493,244 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 9,455,000,000 |
| Annual Net Income | -30,090,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 974,000,000 |
| Last Quarter Sales | 0 | 10,598,000,000 | 2,038,100,000 | 1,354,400,000 | 2,454,000,000 |
| Last Quarter Net Income | -7,230,000 | 1,629,000,000 | 565,100,000 | 3,070,800,000 | 263,000,000 |
| 60-Month Beta | 1.21 | 0.77 | 1.38 | 1.12 | 0.98 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 11/12/24 | 5.28 on 10/23/24 | 1.84 on 10/17/24 | 0.67 on 10/24/24 | 0.81 on 11/12/24 |
| Latest Earnings Date | 11/11/24 | 01/29/25 | 01/28/25 | 02/04/25 | 11/12/24 |
| Most Recent Dividend | N/A | 0.390 on 12/13/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 12/13/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.11 | 97.56 | 27.69 | 27.78 |